FCF yield společnosti Beam Therapeutics
Jaká je hodnota metriky FCF yield společnosti Beam Therapeutics?
Hodnota metriky FCF yield společnosti Beam Therapeutics Inc. je -4.85%
Jaká je definice metriky FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Beam Therapeutics
Čemu se věnuje společnost Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou fcf yield podobnou společnosti Beam Therapeutics
- Hodnota metriky FCF yield společnosti Scully Royalty Ltd je -4.88%
- Hodnota metriky FCF yield společnosti TDK je -4.88%
- Hodnota metriky FCF yield společnosti Sarepta Therapeutics Inc je -4.88%
- Hodnota metriky FCF yield společnosti Calix je -4.88%
- Hodnota metriky FCF yield společnosti Tyro Payments je -4.87%
- Hodnota metriky FCF yield společnosti SNP Schneider-Neureither & Partner SE je -4.87%
- Hodnota metriky FCF yield společnosti Beam Therapeutics je -4.85%
- Hodnota metriky FCF yield společnosti Manitowoc Co je -4.85%
- Hodnota metriky FCF yield společnosti Lightspeed POS je -4.84%
- Hodnota metriky FCF yield společnosti Lachlan Star je -4.84%
- Hodnota metriky FCF yield společnosti Seb Sa je -4.84%
- Hodnota metriky FCF yield společnosti Ponsse Oyj je -4.83%
- Hodnota metriky FCF yield společnosti cbdMD Inc je -4.82%